首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Psychedelic medicine

缩写:PSYCHEDELIC MED

ISSN:2831-4425

e-ISSN:2831-4433

IF/分区:5.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引92
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Marc J Weintraub,Jessica K Jeffrey,Charles S Grob et al. Marc J Weintraub et al.
Background: Recent studies suggest that one to two administrations of psilocybin have acute antidepressant effects for people with major depressive disorder. These data on psilocybin have generated considerable enthusiasm...
Nicholas A Carlisle,Haley Maria Dourron,Sarah MacCarthy et al. Nicholas A Carlisle et al.
Recent trials of psychedelic-assisted therapy have suggested potential efficacy for the treatment of many health conditions that disproportionately impact sexual and gender minority (SGM) people, including major depressive disorder and alco...
Lauren Lepow,Hope Kronman,Rachel Yehuda Lauren Lepow
Introduction: The field of psychedelic research and therapy is growing at an unprecedented rate, as is the need for shared terminology to allow for coherent conversations about these medicines. However, proclaiming consen...
Noah D Gold,Samantha K Podrebarac,Lindsay A White et al. Noah D Gold et al.
Background: More than 50 million people in the United States serve as uncompensated informal caregivers to chronically ill friends or family members. Providing care to a sick loved one can contribute to personal growth bu...
Stephanie Lake,Philippe Lucas Stephanie Lake
Background: Recent years have seen a resurgence in clinical interest in, and increased public acceptance of, psychedelic drugs in Canada. However, our understanding of how psychedelic drugs are currently used in Canada re...
Praachi Tiwari,Andrea P Berghella,Ceyda Sayalı et al. Praachi Tiwari et al.
Background: Emerging literature suggests that classic psychedelics may have efficacy in treating mood and substance use disorders in humans. This has raised questions regarding the primary therapeutic mechanism of these c...
Zachary Herrmann,Adam W Levin,Steven P Cole et al. Zachary Herrmann et al.
Mental health problems including depression, anxiety, suicide, and burnout are common among health care providers. Resilience and well-being are factors thought to protect against these incidents. Clinical trials and naturalistic studies of...
Antonio F Pagán,Claudia Lex,Jair C Soares et al. Antonio F Pagán et al.
Background: Psilocybin and psychedelic-assisted therapy (PAT) have gained renewed interest due to recent findings that PAT can enhance therapeutic outcomes. In 2019, the U.S. Food & Drug Administration (FDA) approved brea...